The DOI matches its Crossref record.
Gram-negative endolysins: overcoming the outer membrane obstacle
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rationally designed constructs, including LysPA26-based hybrids, show strong antibiofilm activity [211,212].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [211]
In the citing paper
“Endolysins and next-generation Artilysins, which fuse lysins with peptides that permeabilize the outer membrane, can lyse P. aeruginosa despite the Gram-negative barrier.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [211]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 66
- Gutiérrez, 2021, Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go, Curr Opin Biotechnol, 68, 15, 10.1016/j.copbio.2020.08.014 · doi:10.1016/j.copbio.2020.08.014
- Love, 2020, On the catalytic mechanism of bacteriophage endolysins: opportunities for engineering, Biochim Biophys Acta (BBA) — Proteins Proteom, 1868, 10.1016/j.bbapap.2019.140302 · DOI
- Fischetti, 2010, Bacteriophage endolysins: a novel anti-infective to control gram-positive pathogens, Int J Med Microbiol, 300, 357, 10.1016/j.ijmm.2010.04.002 · DOI · Paper page
- Chu, 2022, Novel phage lysin Abp013 against Acinetobacter baumannii,, Antibiotics, 11, 196, 10.3390/antibiotics11020169 · DOI
- Larpin, 2018, In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria, PLoS One, 13, 10.1371/journal.pone.0192507 · DOI
- Deng, 2023, The broad-spectrum endolysin LySP2 improves chick survival after Salmonella Pullorum infection, Viruses, 15, 836, 10.3390/v15040836 · doi:10.3390/v15040836
- Euler, 2023, PlyKp104, a novel phage lysin for the treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and other Gram-Negative ESKAPE pathogens, Antimicrob Agents Chemother, 67, 10.1128/aac.01519-22 · DOI
- Vázquez, 2022, Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain, Acta Crystallogr Sect D, 78, 435, 10.1107/S2059798322000936 · doi:10.1107/s2059798322000936
- Thandar, 2016, Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii, Antimicrob Agents Chemother, 60, 2671, 10.1128/AAC.02972-15 · DOI
- Abdelkader, 2020, Lysin LysMK34 of Acinetobacter baumannii bacteriophage PMK34 has a turgor pressure-dependent intrinsic antibacterial activity and reverts colistin resistance, Appl Environ Microbiol, 86, 19, 10.1128/AEM.01311-20 · DOI
- Wang, 2020, TSPphg lysin from the extremophilic thermus bacteriophage TSP4 as a potential antimicrobial agent against both Gram-Negative and Gram-Positive pathogenic bacteria, Viruses, 12, 192, 10.3390/v12020192 · DOI
- Plotka, 2019, Ts2631 endolysin from the extremophilic Thermus scotoductus bacteriophage vB_Tsc2631 as an antimicrobial agent against gram-negative multidrug-resistant bacteria, Viruses, 11, 10.3390/v11070657 · DOI
- Abdelrahman, 2023, Pseudomonas phage ZCPS1 endolysin as a potential therapeutic agent, Viruses, 15, 520, 10.3390/v15020520 · DOI
- Premetis, 2023, Metaviromics analysis of marine biofilm reveals a glycoside hydrolase endolysin with high specificity towards Acinetobacter baumannii, Biochim Biophys Acta Proteins Proteom, 1871, 10.1016/j.bbapap.2023.140918 · DOI
- Premetis, 2023, Characterization of a glycoside hydrolase endolysin from Acinetobacter baumannii phage AbTZA1 with high antibacterial potency and novel structural features, Febs J, 290, 2146, 10.1111/febs.16686 · DOI
- Wang, 2020, MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria, Virol J, 17, 10.1186/s12985-020-01403-0 · doi:10.1186/s12985-020-01403-0
- Peng, 2017, Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2, Sci Rep, 7, 1, 10.1038/s41598-017-11832-7 · DOI
- Raz, 2019, Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection, Antimicrob Agents Chemother, 63, 10.1128/AAC.00024-19 · DOI
- Vázquez, 2022, Improvement of the antibacterial activity of phage lysin-derived peptide P87 through maximization of physicochemical properties and assessment of its therapeutic potential, Antibiotics, 11, 10.3390/antibiotics11101448 · doi:10.3390/antibiotics11101448
- Gontijo, 2021, Current status of endolysin-based treatments against Gram-Negative bacteria, Antibiotics, 10, 10.3390/antibiotics10101143 · DOI
- Oliveira, 2016, Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-gram-negative bacterial activity, Frontiers in Microbiology, 7, 10.3389/fmicb.2016.00208 · DOI
- Ni, 2021, Characterization of a lytic bacteriophage against Pseudomonas syringae pv. actinidiae and its endolysin, Viruses, 13, 10.3390/v13040631 · doi:10.3390/v13040631
- Walmagh, 2013, Characterization of five novel endolysins from Gram-negative infecting bacteriophages, Appl Microbiol Biotechnol, 97, 4369, 10.1007/s00253-012-4294-7 · DOI
- Nie, 2022, An endolysin Salmcide-p1 from bacteriophage fmb-p1 against gram-negative bacteria, J Appl Microbiol, 133, 1597, 10.1111/jam.15661 · DOI
- Briers, 2011, Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa, J Appl Microbiol, 110, 778, 10.1111/j.1365-2672.2010.04931.x · DOI · Paper page
- Banfi, 2007, The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes, Clin Chem Lab Med, 45, 565, 10.1515/CCLM.2007.110 · DOI · Paper page
- Egli, 2001, Biodegradation of metal-complexing aminopolycarboxylic acids, J Biosci Bioeng, 92, 89, 10.1016/S1389-1723(01)80207-3 · doi:10.1016/s1389-1723(01)80207-3
- Sisson, 2024, Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae, Appl Environ Microbiol, 90
- Zermeño-Cervantes, 2023, Evaluating the efficacy of endolysins and membrane permeabilizers against Vibrio parahaemolyticus in marine conditions, Res Microbiol, 174, 10.1016/j.resmic.2023.104104 · doi:10.1016/j.resmic.2023.104104
- Blasco, 2020, In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens, Sci Rep, 10, 10.1038/s41598-020-64145-7 · DOI
- Hong, 2022, Combination effect of engineered endolysin EC340 with antibiotics, Front Microbiol, 13, 10.3389/fmicb.2022.821936 · DOI
- Baliga, 2023, Cloning, characterization, and antibacterial properties of endolysin LysE against planktonic cells and biofilms of Aeromonas hydrophila, Probiotics Antimicrob Proteins, 15, 646, 10.1007/s12602-021-09880-7 · doi:10.1007/s12602-021-09880-7
- Kim, 2023, Combined antimicrobial effect of phage-derived endolysin and depolymerase against biofilm-forming Salmonella Typhimurium, Biofouling, 39, 763, 10.1080/08927014.2023.2265817 · doi:10.1080/08927014.2023.2265817
- Shen, 2023, Characterization of a broad-spectrum endolysin rLysJNwz and its utility against Salmonella in foods, Appl Microbiol Biotechnol, 107, 3229, 10.1007/s00253-023-12500-9 · doi:10.1007/s00253-023-12500-9
- Ning, 2021, Synergistic effects of endolysin Lysqdvp001 and ε-poly-lysine in controlling Vibrio parahaemolyticus and its biofilms, Int J Food Microbiol, 343, 10.1016/j.ijfoodmicro.2021.109112 · doi:10.1016/j.ijfoodmicro.2021.109112
- Briers, 2014, Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa, Antimicrob Agents Chemother, 58, 3774, 10.1128/AAC.02668-14 · DOI · Paper page
- Schirmeier, 2018, Inhibitory and bactericidal effect of Artilysin® Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates, Int J Antimicrob Agents, 51, 528, 10.1016/j.ijantimicag.2017.08.027 · DOI
- Defraine, 2016, Efficacy of artilysin art-175 against resistant and persistent Acinetobacter baumannii, Antimicrob Agents Chemother, 60, 3480, 10.1128/AAC.00285-16 · DOI
- Wang, 2021, Design SMAP29-LysPA26 as a highly efficient artilysin against Pseudomonas aeruginosa with bactericidal and antibiofilm activity, Microbiol Spectr, 9, 10.1128/Spectrum.00546-21 · DOI · Paper page
- Jeong, 2023, Characterization of three different endolysins effective against Gram-Negative bacteria, Viruses, 15, 679, 10.3390/v15030679 · doi:10.3390/v15030679
- Islam, 2022, Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii, Front Microbiol, 13, 10.3389/fmicb.2022.988522 · doi:10.3389/fmicb.2022.988522
- Lim, 2022, Bactericidal effect of cecropin A fused endolysin on drug-resistant Gram-Negative pathogens, J Microbiol Biotechnol, 32, 816, 10.4014/jmb.2205.05009 · DOI
- Gerstmans, 2020, A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins, Sci Adv, 6, 10.1126/sciadv.aaz1136 · DOI
- Gerstmans, 2023, Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria, Microbiol Spectr, 6
- Chen, 2021, Membrane-permeable antibacterial enzyme against multidrug-resistant Acinetobacter baumannii, ACS Infect Dis, 7, 2192, 10.1021/acsinfecdis.1c00222 · doi:10.1021/acsinfecdis.1c00222
- Abdelkader, 2022, Engineering a lysin with Intrinsic Antibacterial Activity (LysMK34) by cecropin A fusion enhances its antibacterial properties against Acinetobacter baumannii, Appl Environ Microbiol, 88, e01515, 10.1128/AEM.01515-21 · doi:10.1128/aem.01515-21
- Wang, 2023, Crystal structure of the engineered endolysin mtEC340M, Acta Crystallogr Sect F Struct Biol Commun, 79, 105, 10.1107/S2053230X23002583 · doi:10.1107/s2053230x23002583
- Ning, 2021, Development of cationic peptide chimeric lysins based on phage lysin Lysqdvp001 and their antibacterial effects against Vibrio parahaemolyticus: a preliminary study, Int J Food Microbiol, 358, 10.1016/j.ijfoodmicro.2021.109396 · doi:10.1016/j.ijfoodmicro.2021.109396
- Wang, 2022, A single catalytic endolysin domain Plychap001: characterization and application to control Vibrio parahaemolyticus and its biofilm directly, Foods, 11, 1578, 10.3390/foods11111578 · doi:10.3390/foods11111578
- Nie, 2021, In Silico development of novel chimeric lysins with highly specific inhibition against Salmonella by computer-aided design, J Agric Food Chem, 69, 3751, 10.1021/acs.jafc.0c07450 · doi:10.1021/acs.jafc.0c07450
- Lim, 2022, Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin, J Microbiol, 60, 859, 10.1007/s12275-022-2107-y · doi:10.1007/s12275-022-2107-y
- Sitthisak, 2023, Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii, Sci Rep, 13, 10.1038/s41598-023-33822-8 · DOI
- Sui, 2023, Design, screening, and characterization of engineered phage endolysins with extracellular antibacterial activity against Gram-Negative Bacteria, Appl Environ Microbiol, 89, e00581, 10.1128/aem.00581-23 · doi:10.1128/aem.00581-23
- Ning, 2023, Development of highly efficient artilysins against Vibrio parahaemolyticus via virtual screening assisted by molecular docking, Food Control, 146, 10.1016/j.foodcont.2022.109521 · doi:10.1016/j.foodcont.2022.109521
- Heselpoth, 2019, Lysocins: Bioengineered antimicrobials that deliver lysins across the outer membrane of Gram-negative bacteria, Antimicrob Agents Chemother, 63, 10.1128/AAC.00342-19 · DOI
- Lukacik, 2012, Structural engineering of a phage lysin that targets Gram-negative pathogens, Proc Natl Acad Sci, 109, 9857, 10.1073/pnas.1203472109 · DOI
- Yan, 2017, The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly, Int J Gen Mol Microbiol, 110, 1627
- Nobrega, 2018, Targeting mechanisms of tailed bacteriophages, Nat Rev Microbiol, 16, 760, 10.1038/s41579-018-0070-8 · DOI · Paper page
- Zampara, 2020, Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria, Sci Rep, 10, 10.1038/s41598-020-68983-3 · DOI
- Zampara, 2021, Developing innolysins against Campylobacter jejuni using a novel prophage receptor-binding protein, Frontiers in Microbiology, 12, 10.3389/fmicb.2021.619028 · doi:10.3389/fmicb.2021.619028
- Athina, 2023, Martine Camilla Holst S: Campycins are novel broad spectrum antibacterials killing Campylobacter jejuni by targeting the essential major outer membrane protein (MOMP), bioRxiv
- Warring, 2022, A lipopolysaccharide-dependent phage infects a pseudomonad phytopathogen and can evolve to evade phage resistance, Environ Microbiol, 24, 4834, 10.1111/1462-2920.16106 · DOI
- Vázquez, 2021, Mining of Gram-Negative surface-active enzybiotic candidates by sequence-based calculation of physicochemical properties, Frontiers in Microbiology, 12, 10.3389/fmicb.2021.660403 · DOI
- Schuch, 2022, Direct lytic agents: novel, rapidly acting potential antimicrobial treatment modalities for systemic use in the era of rising antibiotic resistance, Front Microbiol, 13, 10.3389/fmicb.2022.841905 · doi:10.3389/fmicb.2022.841905
- Li, 2023, LysP53 activity against Salmonella and its application in decontamination of Salmonella on fresh romaine lettuce, Appl Microbiol Biotechnol, 107, 5403, 10.1007/s00253-023-12666-2 · doi:10.1007/s00253-023-12666-2
- Hancock, 1984, Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane, Antimicrob Agents Chemother, 26, 48, 10.1128/AAC.26.1.48 · DOI · Paper page
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Ceballos-Zúñiga, F., Galvez-Larrosa, L., Muñoz, I. G., Infantes, L., Fernández-Carrillo, J., & Pérez-Dorado, I. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148896 · Cited by 4
Metadata
- Authors
- Sisson, H. M., Jackson, S. A., Fagerlund, R. D., Warring, S. L., & Fineran, P. C.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2024-04
- Volume
- 78
- Pages
- 102433
- ISSN
- 1369-5274
- Cited by
- 77
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gram-negative endolysins: overcoming the outer membrane obstacle. https://app.cochat.ai/papers/10.1016/j.mib.2024.102433
- The paper
- Sisson, H. M., Jackson, S. A., Fagerlund, R. D., Warring, S. L., & Fineran, P. C. (2024). Gram-negative endolysins: overcoming the outer membrane obstacle. Current Opinion in Microbiology. https://doi.org/10.1016/j.mib.2024.102433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.